SMMT. We are going for the Peak of the Summit.SMMT. We are going for the Peak of the Summit.
High insider value. High institional value. Algo is loading.
−1.58USD
−78.782MUSD
705KUSD
111.774M
About Summit Therapeutics Inc.
Sector
Industry
Headquarters
Menlo Park
Website
Employees (FY)
77
Founded
2003
ISIN
US86627T1088
Summit Therapeutics, Inc. a biopharmaceutical company, which discovers, develops, and commercializes medicines to treat infectious diseases. The firm conducts clinical programs focusing on Clostridioides Difficile Infection (CDI). Its lead product, Ridinilazole, is an orally administered small molecule antibiotic that is in Phase III clinical trials for the treatment of CDI. The company was founded in 2003 and is headquartered in Menlo Park, CA.
After a big run like this, all of these low floats end up dudsAfter a big run like this, all of these low floats end up in the tank. Just speculating that this will follow tradition.
$SMMT Heavy Insider Buying $SMMT insider ownership is crazy high and the CEO owns 162+ Mil shares by himself, that’s crazy confidence!
Insider Ownership 82%
cdn.discordapp.com
media.discordapp.net
www.sec.gov
NASDAQ:SMMT
$SMMT Next Target PT 2 and higherSummit Therapeutics Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat infectious diseases in the United States and Latin America. It conducts clinical programs focusing on Clostridioides difficile infection (CDI). The company's lead product candidate is ri
SMMT GAP FILL potentialBreaking Key area, and Also major resistance and can go back to down side to the consolidation zone. signs look bullish, but a key area to watch.
Have a Happy Day
SMMT GAP FILL potentialReversal on the 4 hour, from a huge drop in Dec due to poor results for their trials when they combined data. They said 2022 end of 1st quarter they will release an update. They stopped the offering to investors and will give an update later.
52 Week low, Analyst Buy recommendations 6 Buy, 3 Hold, 0 SellThis may be catching a falling knife, but I found SMMT on my scanner after it was down 50% in a day
If you look at all the analyst ratings on this stock there's no reason it should be down where it is right now.
It's down to $2.44 right now at it's 52 week low when just weeks ago it was worth $12 a
$SMMT can rise in the next daysContextual immersion trading strategy idea.
Summit Therapeutics Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat infectious diseases in the United States, Latin America, and Europe.
The demand for shares of the company looks higher than the supply.
Th
See all ideas
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
